... York-based company said it had net income of 1 cent. The life sciences and biotechnology company posted revenue of $28.7 million in the period.
News
- Enzo Biochem: Fiscal 1Q Earnings Snapshot
- Greenwich LifeSciences Surges 2000%, Halted Multiple Times Following Breast Cancer Drug ...
... presented Wednesday at the 2020 San Antonio Breast Cancer Symposium. Greenwich LifeSciences is a clinical stage bio-pharmaceutical company ...
- 52 Stocks Moving In Wednesday's Mid-Day Session
... from ongoing Phase 2 MARIO-3 Trial at San Antonio Breast Cancer Symposium. ... Aytu Bioscience, last week, disclosed it established purchasing relationship with ... Oncolytics Biotech Inc. (NASDAQ: ONCY) fell 17.4% to $3.17.
- News briefing: Assembly Bio scraps microbiome programs; InveniAI, Kyowa Kirin expand ...
Assembly Biosciences said the decision was “not based on any efficacy, ... The 21-year-old, New York-based biotech announced Phase I data for its gene ... unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- RA Capital backs Oxford spinout PepGen with a $45M Series A, seeking to treat Duchenne and ...
The biotech says that the cell-penetrating nature of the peptides, when ... unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.